Comparative study of five commercial probes for the detection of Epstein-Barr virus (EBV) by in situ hybridization in cases of nodular sclerosis Hodgki's lymphoma

ABSTRACT Introduction: Epstein-Barr virus (EBV) may serve as a target in therapeutic treatments, thus reliable diagnostic results are necessary. Objective: The aim of this study was to evaluate the accuracy of EBV detection by in situ hybridization (ISH) using five commercial probes in formalin-fi...

Full description

Bibliographic Details
Main Authors: Suely Nonogaki, Neuza K. Shirata, Lidia M. Kimura, Juliana M. Guerra, Raphael S. S. Medeiros, Roberto Antonio P. Paes, Cristina T. Kanamura, Camila C. Oliveira, Yara de Menezes
Format: Article
Language:English
Published: Sociedade Brasileira de Patologia Clínica
Series:Jornal Brasileiro de Patologia e Medicina Laboratorial
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442016000600416&lng=en&tlng=en
_version_ 1818209957935316992
author Suely Nonogaki
Neuza K. Shirata
Lidia M. Kimura
Juliana M. Guerra
Raphael S. S. Medeiros
Roberto Antonio P. Paes
Cristina T. Kanamura
Camila C. Oliveira
Yara de Menezes
author_facet Suely Nonogaki
Neuza K. Shirata
Lidia M. Kimura
Juliana M. Guerra
Raphael S. S. Medeiros
Roberto Antonio P. Paes
Cristina T. Kanamura
Camila C. Oliveira
Yara de Menezes
author_sort Suely Nonogaki
collection DOAJ
description ABSTRACT Introduction: Epstein-Barr virus (EBV) may serve as a target in therapeutic treatments, thus reliable diagnostic results are necessary. Objective: The aim of this study was to evaluate the accuracy of EBV detection by in situ hybridization (ISH) using five commercial probes in formalin-fixed and paraffin-embedded samples of nodular sclerosis Hodgkin's lymphoma (HL), and to compare the results with immunohistochemistry (IHC) and polymerase chain reaction (PCR). Material and method: Thirty samples were selected, 28 were lymph nodes, one bone marrow and one mediastinum. The following parameters were analyzed: signal intensity; proportionality of positive cells; quality of the reaction according to comfort for evaluation, sign quality and homogeneity of labeled cells; background reaction; morphology; presence of artifacts; and positivity in other non-neoplastic cells. All samples were analyzed for EBV detection using the five probes, IHC for latent membrane protein type 1 (LMP1) and PCR for Epstein Barr virus nuclear antigen 1 (EBNA1). Statistical analyses were performed with the R1 software; Fleiss' test and Cohen Kappa index of 5% were considered significant. Results: The detection by IHC-LMP1 was 26.7% (8/30) and 66.7% (20/30) by PCR-EBNA1. All probes detected EBV. Positivity was observed in 42/90 (46.7%), 38/90 (42.2%), 45/90 (50%), 27/90 (30%) and 61/90 (67.8%) for probes A, B, C, D and E, respectively. Discussion: All five probes demonstrated positivity. Conclusion: Probe E showed better rate (67.8%), sensitivity, specificity and accuracy (100%), a very good correlation among the different observers and with PCR, besides great cost-benefits relation.
first_indexed 2024-12-12T05:08:58Z
format Article
id doaj.art-b0bb99e3f4d04ae195f9e7314d0baaca
institution Directory Open Access Journal
issn 1676-2444
1678-4774
language English
last_indexed 2024-12-12T05:08:58Z
publisher Sociedade Brasileira de Patologia Clínica
record_format Article
series Jornal Brasileiro de Patologia e Medicina Laboratorial
spelling doaj.art-b0bb99e3f4d04ae195f9e7314d0baaca2022-12-22T00:37:01ZengSociedade Brasileira de Patologia ClínicaJornal Brasileiro de Patologia e Medicina Laboratorial1676-24441678-477452641642510.5935/1676-2444.20160065S1676-24442016000600416Comparative study of five commercial probes for the detection of Epstein-Barr virus (EBV) by in situ hybridization in cases of nodular sclerosis Hodgki's lymphomaSuely NonogakiNeuza K. ShirataLidia M. KimuraJuliana M. GuerraRaphael S. S. MedeirosRoberto Antonio P. PaesCristina T. KanamuraCamila C. OliveiraYara de MenezesABSTRACT Introduction: Epstein-Barr virus (EBV) may serve as a target in therapeutic treatments, thus reliable diagnostic results are necessary. Objective: The aim of this study was to evaluate the accuracy of EBV detection by in situ hybridization (ISH) using five commercial probes in formalin-fixed and paraffin-embedded samples of nodular sclerosis Hodgkin's lymphoma (HL), and to compare the results with immunohistochemistry (IHC) and polymerase chain reaction (PCR). Material and method: Thirty samples were selected, 28 were lymph nodes, one bone marrow and one mediastinum. The following parameters were analyzed: signal intensity; proportionality of positive cells; quality of the reaction according to comfort for evaluation, sign quality and homogeneity of labeled cells; background reaction; morphology; presence of artifacts; and positivity in other non-neoplastic cells. All samples were analyzed for EBV detection using the five probes, IHC for latent membrane protein type 1 (LMP1) and PCR for Epstein Barr virus nuclear antigen 1 (EBNA1). Statistical analyses were performed with the R1 software; Fleiss' test and Cohen Kappa index of 5% were considered significant. Results: The detection by IHC-LMP1 was 26.7% (8/30) and 66.7% (20/30) by PCR-EBNA1. All probes detected EBV. Positivity was observed in 42/90 (46.7%), 38/90 (42.2%), 45/90 (50%), 27/90 (30%) and 61/90 (67.8%) for probes A, B, C, D and E, respectively. Discussion: All five probes demonstrated positivity. Conclusion: Probe E showed better rate (67.8%), sensitivity, specificity and accuracy (100%), a very good correlation among the different observers and with PCR, besides great cost-benefits relation.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442016000600416&lng=en&tlng=eninfecções pelo vírus epstein-barrhibridização in situdoença de hodgkin
spellingShingle Suely Nonogaki
Neuza K. Shirata
Lidia M. Kimura
Juliana M. Guerra
Raphael S. S. Medeiros
Roberto Antonio P. Paes
Cristina T. Kanamura
Camila C. Oliveira
Yara de Menezes
Comparative study of five commercial probes for the detection of Epstein-Barr virus (EBV) by in situ hybridization in cases of nodular sclerosis Hodgki's lymphoma
Jornal Brasileiro de Patologia e Medicina Laboratorial
infecções pelo vírus epstein-barr
hibridização in situ
doença de hodgkin
title Comparative study of five commercial probes for the detection of Epstein-Barr virus (EBV) by in situ hybridization in cases of nodular sclerosis Hodgki's lymphoma
title_full Comparative study of five commercial probes for the detection of Epstein-Barr virus (EBV) by in situ hybridization in cases of nodular sclerosis Hodgki's lymphoma
title_fullStr Comparative study of five commercial probes for the detection of Epstein-Barr virus (EBV) by in situ hybridization in cases of nodular sclerosis Hodgki's lymphoma
title_full_unstemmed Comparative study of five commercial probes for the detection of Epstein-Barr virus (EBV) by in situ hybridization in cases of nodular sclerosis Hodgki's lymphoma
title_short Comparative study of five commercial probes for the detection of Epstein-Barr virus (EBV) by in situ hybridization in cases of nodular sclerosis Hodgki's lymphoma
title_sort comparative study of five commercial probes for the detection of epstein barr virus ebv by in situ hybridization in cases of nodular sclerosis hodgki s lymphoma
topic infecções pelo vírus epstein-barr
hibridização in situ
doença de hodgkin
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442016000600416&lng=en&tlng=en
work_keys_str_mv AT suelynonogaki comparativestudyoffivecommercialprobesforthedetectionofepsteinbarrvirusebvbyinsituhybridizationincasesofnodularsclerosishodgkislymphoma
AT neuzakshirata comparativestudyoffivecommercialprobesforthedetectionofepsteinbarrvirusebvbyinsituhybridizationincasesofnodularsclerosishodgkislymphoma
AT lidiamkimura comparativestudyoffivecommercialprobesforthedetectionofepsteinbarrvirusebvbyinsituhybridizationincasesofnodularsclerosishodgkislymphoma
AT julianamguerra comparativestudyoffivecommercialprobesforthedetectionofepsteinbarrvirusebvbyinsituhybridizationincasesofnodularsclerosishodgkislymphoma
AT raphaelssmedeiros comparativestudyoffivecommercialprobesforthedetectionofepsteinbarrvirusebvbyinsituhybridizationincasesofnodularsclerosishodgkislymphoma
AT robertoantonioppaes comparativestudyoffivecommercialprobesforthedetectionofepsteinbarrvirusebvbyinsituhybridizationincasesofnodularsclerosishodgkislymphoma
AT cristinatkanamura comparativestudyoffivecommercialprobesforthedetectionofepsteinbarrvirusebvbyinsituhybridizationincasesofnodularsclerosishodgkislymphoma
AT camilacoliveira comparativestudyoffivecommercialprobesforthedetectionofepsteinbarrvirusebvbyinsituhybridizationincasesofnodularsclerosishodgkislymphoma
AT yarademenezes comparativestudyoffivecommercialprobesforthedetectionofepsteinbarrvirusebvbyinsituhybridizationincasesofnodularsclerosishodgkislymphoma